Fordham 33 (Report 5): Trade secrets By Annsley Merelle Ward on Tuesday, April 14, 2026 #IPKat AmeriKat compulsory licences confidentiality agreements DTSA employee Fordham Fordham 2026 fordham 33 trade secrets +
Book Review: Mechanisms to Enable Follow-On Innovation By Anastasiia Kyrylenko on Wednesday, September 14, 2022 Anastasiia Kyrylenko Art. 102 TFEU Book review competition law compulsory licences open innovation patents +
Never Too Late: if you missed the IPKat last week By Sophie Corke on Friday, May 22, 2020 ‘The Right of Publicity: Privacy Reimagined for a Public World’ compulsory licences copyright FRAND Jennifer Rothman patents review SEPs Sophie Corke trade marks +
[Guest Post] COVID-19: The Invisible Enemy Revisited By Verónica Rodríguez Arguijo on Tuesday, April 07, 2020 AH1N1 compulsory licences compulsory licenses COVID-19 Guest post Mexican law Mexico pandemic patents +
No deal Brexit - what will happen to patents - particularly SPCs and the UPC? By Rosie Burbidge on Tuesday, September 25, 2018 biotech Brexit Brexit patents compulsory licences EU european union patents SPC Unified Patent Court unitary patent upc +
Never Too Late: If you missed the IPKat Last Week! By Cecilia Sbrolli on Friday, July 21, 2017 academic research compulsory licences digital exhaustion doctrine of equivalents Orphan works trade secrets +
BGH grants compulsory license in preliminary proceedings By Mark Schweizer on Wednesday, July 12, 2017 compulsory licences German patent law +
A Monsanto case that could alter the dynamics of technology transfer to India By Darren Smyth on Friday, March 04, 2016 competition law compulsory licences crop resistance india monsanto +
Australia, TRIPS and compulsory pharma licences for LDCs: reaching the endgame By Jeremy on Tuesday, March 10, 2015 Australia compulsory licences Jeremy Phillips pharmaceuticals TRIPS Protocol +